Rebus Holdings, Inc.

OTC: RBSH · Healthcare · Biotechnology

PublicHQ Westlake Village, CA · Los AngelesCIK 0001421204Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 25

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, listing tenure · ↓ workforce scale, balance-sheet leverage

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.0M

Employees

Market cap

$3.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$1.0M-$1.0M2022

Operating income-$664.0k-$664.0k2022

Total assets$5.0k$5.0k2022

Liabilities$5.2M$5.2M2022

Equity-$5.2M-$5.2M2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Rebus Holdings, Inc. earned -$1.0M in FY2022 net income.

Peers · Healthcare

Regen BioPharma, Inc.37D Sproutly Canada Inc.——NewCardio, Inc.——Sienna Biopharmaceuticals, Inc.——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B71B Rocket Lab USA, Inc.$601.8M50D Public Storage$4.8B79B+Live Nation Entertainment, Inc.$25.2B76B+Ares Management Corporation$5.6B67B Edison International$19.3B81B+

Key facts

CEORaul Silvestre

SectorHealthcare

IndustryBiotechnology

HeadquartersWestlake Village, CA

ExchangeOTC: RBSH

Employees1

IPO date2009-11-04

Latest filings

10-Q2023-08-21 10-Q2023-05-15 10-K2023-03-31 10-Q2022-11-21 8-K2022-11-16 8-K2022-10-13 10-Q2022-08-12 10-Q2022-05-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.